A method using high-performance thin-layer chromatography (HPTLC) for quantitation of sertraline in human serum was developed and validated. It includes a liquid-liquid extraction with diethyl ether-chlorophorm (75:25, v/v) and carbamazepine as internal standard. Chromatographic separation was performed on precoated silica gel F254 HPTLC plates using a mixture of toluene-ethyl acetate-methanol-glacial acetic acid (4.5:1.5:1.0:0.5, v/v) as mobile phase. The method showed good relationship (r = 0.998) (1.00–70.00 ng/band, corresponding to 0.01 and 0.70 ng/μL in serum after extraction process and applying 10 μL to the chromatographic plates). This range includes serum concentration found in literature (0.02–0.50 ng/μL). The % RSD values of intra- and inter-assay were between 0.88–2.75 and 0.76–3.36, respectively. The limit of detection and the limit of quantification were 0.12 and 0.25 ng/band. The accuracy values were between 94.65% and 98.93%. RF for N-desmethylsertraline or norsertraline (major metabolite of sertraline), sertraline, and carbamazepine were 0.23, 0.45, and 0.71, respectively. Ten samples of patient volunteers who were using sertraline as a treatment for major depression were analyzed using the method developed and found sertraline concentrations between 0.05 and 0.32 ng/μL. In conclusion, the method is precise, accurate, selective, and sensitive for quantitative determination of sertraline in human serum, and it could be used for pharmacotherapy adherence evaluation.
J. Mc Namara, in: J. Hardman, L. Limbird (eds.), Las Bases Farmacológicas de la Terapéutica, Mc Graw-Hill, México, 2003.
Mc Namara J., '', in Las Bases Farmacológicas de la Terapéutica, (2003) -.
Mc Namara J.Las Bases Farmacológicas de la Terapéutica2003)| false
G. McEvoy, AHFS Drug Information, American Society of Health-System Pharmacists, Bethesda, 2009.
McEvoy G., '', in AHFS Drug Information, (2009) -.
McEvoy G.AHFS Drug Information2009)| false
S. Sweetman, Martindale, Guía Completa de Consulta Farmacoterapéutica, Pharma Editores S.L, Barcelona, 2003.
A. Akincigil, Med. Care 45 (2007) 363–369.
Akincigil A., '' (2007) 45Med. Care: 363-369.
Akincigil A.Med. Care200745363369)| false
S. Pampallona, P. Bollini, B. Tibaldi, B. Kupelnick, C. Munizza, Br. J. Psychiatry 180 (2002) 104–109.
Munizza C., '' (2002) 180Br. J. Psychiatry: 104-109.
Munizza C.Br. J. Psychiatry2002180104109)| false
K. Demyttenaere, Eur. Neuropsychopharmacol. 13 (2003) 69–75
Demyttenaere K., '' (2003) 13Eur. Neuropsychopharmacol.: 69-75.